World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
24737
World Ranking
1181
National Ranking
624

Medicine

D-Index
88
Citations
24921
World Ranking
13283
National Ranking
6763

Allan D. Kirk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Allan D. Kirk sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 462 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Allan D. Kirk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Allan D. Kirk sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Allan D. Kirk is affiliated with Duke University in the United States. Their research primarily falls within the field of Medicine, with a focus on Surgery, Immunology, and Transplantation. The body of work includes significant contributions to areas such as Renal Transplantation Outcomes and Treatments, Xenotransplantation and immune response, and T-cell and B-cell Immunology.

The scientist's recent papers demonstrate active engagement with transplant immunology and surgical outcomes. Notable publications include:

  • Roadmap for Transforming Preoperative Assessment to Preoperative Optimization, 2020, Anesthesia & Analgesia
  • A comparison of deprivation indices and application to transplant populations, 2023, American Journal of Transplantation
  • The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates, 2023, Science Translational Medicine
  • Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up, 2020, American Journal of Transplantation
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients, 2020, American Journal of Transplantation

Frequent coauthors collaborating with Allan D. Kirk include:

  • Brian I. Shaw
  • Eric A. Elster
  • Lisa M. McElroy
  • Seth Schobel
  • Linda Stempora

The scientist publishes regularly in several venues, with a concentration of work appearing in the following journals:

  • American Journal of Transplantation
  • Annals of Surgery Open
  • Annals of Surgery
  • Surgery
  • The Journal of Trauma: Injury, Infection, and Critical Care

The main topics covered in their research include:

  • Renal Transplantation Outcomes and Treatments
  • Xenotransplantation and immune response
  • T-cell and B-cell Immunology
  • Organ Transplantation Techniques and Outcomes
  • Immune Cell Function and Interaction
  • Organ Donation and Transplantation
  • Cardiac, Anesthesia and Surgical Outcomes

Subfields of their study encompass Surgery, Immunology, Transplantation, Pulmonary and Respiratory Medicine, and Public Health, Environmental and Occupational Health, reflecting a multidisciplinary approach within medical research.

Best Publications

  • CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

    Allan D. Kirk;David M. Harlan;Nicholas N. Armstrong;Thomas A. Davis

  • Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.

    Allan D. Kirk;Allan D. Kirk;Allan D. Kirk;Linda C. Burkly;D. Scott Batty;Roxanne E. Baumgartner

  • Identification of a B cell signature associated with renal transplant tolerance in humans

    Kenneth A. Newell;Adam Asare;Allan D. Kirk;Trang D. Gisler

  • The Banff 2007 working classification of skin-containing composite tissue allograft pathology.

    L. C. Cendales;J. Kanitakis;S. Schneeberger;S. Schneeberger;C. Burns

  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154

    Norma S. Kenyon;Maria Chatzipetrou;Michele Masetti;Alessandra Ranuncoli

  • Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.

    Jonathan P. Pearl;Jeremy Parris;Douglas A. Hale;Douglas A. Hale;Steven C. Hoffmann

  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

    Allan D. Kirk;Douglas A. Hale;Roslyn B. Mannon;David E. Kleiner

  • Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

    Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Nancy Craighead

  • ETHNICITY GREATLY INFLUENCES CYTOKINE GENE POLYMORPHISM DISTRIBUTION

    Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Barbara S. DiMercurio

  • Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

    Ravi S. Chari;Bradley H. Collins;John C. Magee;J. Michael Dimaio

  • The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts

    Scott K. Pruitt;Allan D. Kirk;R. Randal Bollinger;Henry C. Marsh

  • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.

    Norma S. Kenyon;Luis A. Fernandez;Roger Lehmann;Michele Masetti

  • Donor leukocyte infusions in acute lymphocytic leukemia.

    Robert H Collins;S. Goldstein;S. Giralt;J. Levine

  • CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.

    Patrick J. Blair;James L. Riley;David M. Harlan;Ryo Abe

  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

    Tim A Weaver;Ali H Charafeddine;Ali H Charafeddine;Avinash Agarwal;Alexandra P Turner

  • Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection

    Jennifer A. Jackson;Eugenia J. Kim;Beth Begley;Jennifer Cheeseman

  • Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab.

    A. D. Kirk;W. S. Cherikh;M. Ring;G. Burke

  • Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6.

    Cox Ed;Hoffmann Sc;DiMercurio Bs;Wesley Ra

  • Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

    Marinos C. Dalakas;Goran Rakocevic;Jens Schmidt;Mohammad Salajegheh

  • The role of donor-specific HLA alloantibodies in liver transplantation.

    J.G. O'Leary;A.J. Demetris;L.S. Friedman;Howard Gebel

Frequent Co-Authors

Christian P. Larsen
Christian P. Larsen Emory University
Stuart J. Knechtle
Stuart J. Knechtle Duke University
David E. Kleiner
David E. Kleiner National Institutes of Health
Mandy L. Ford
Mandy L. Ford Emory University
Linda C. Burkly
Linda C. Burkly Biogen (United States)
Thomas C. Pearson
Thomas C. Pearson Emory University
Hans W. Sollinger
Hans W. Sollinger University of Wisconsin–Madison
Keith A. Reimann
Keith A. Reimann Harvard Medical School
John D. Pirsch
John D. Pirsch University of Wisconsin–Madison
Bruce R. Blazar
Bruce R. Blazar University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens the door to various healthcare and research careers, many of which can be enhanced through specialized online programs. For those interested in psychiatric nursing, exploring the best pmhnp programs offers insight into top-tier education combined with strong clinical placements, crucial for hands-on experience.

Cost is always a factor, and finding affordable pmhnp programs can make advanced nursing education more accessible without compromising quality. This is especially important for working professionals aiming to balance study and work.

Understanding the salary outlook is key for career planning. Knowing how much do dnp nurses make helps gauge the return on investment for a Doctor of Nursing Practice degree and can guide decisions about location and specialty.

For nurses contemplating a shift in focus, certification, such as acute care np certification, provides a pathway to new roles in critical care environments. These credentials broaden career options and enhance expertise in patient management.

Best Scientists Citing Allan D. Kirk

Trending Scientists

Recently Published Articles